1. Epidermal melanocytes in segmental vitiligo show altered expression of E‐cadherin, but not P‐cadherin. (1st May 2018) Authors: Grill, C.; Benzekri, L.; Rubod, A.; Aktary, Z.; Ezzedine, K.; Taïeb, A.; Gauthier, Y.; Larue, L.; Delmas, V. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epidermal melanocytes in segmental vitiligo show altered expression of E‐cadherin, but not P‐cadherin. (25th March 2018) Authors: Grill, C.; Benzekri, L.; Rubod, A.; Aktary, Z.; Ezzedine, K.; Taïeb, A.; Gauthier, Y.; Larue, L.; Delmas, V. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Grandclement, C.; Estoppey, C.; Dheilly, E.; Panagopoulou, M.; Martini, E.; Labanca, V.; De Angelis, S.; Frei, J.; Drake, A.; Rubod, A.; Gudi, G.; Udupa, V.; Koch Olsen, J.; Giovannini, R.; Doucey, M. A.; Feldman, E.; Konto, C.; Srivastava, A.; Perro, M.; Sammicheli, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗